Insulin, GLP-1 and oral hypoglycaemic agents Flashcards

1
Q

Aim of diabetes treatment

A
  • education for self management
  • focus on lifestyle and diet changes
  • psychological and social support
  • CV RF control avoiding complications
  • regularly screening for complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diabetic Annual Review

A
  • min. twice a year
  • symptom review
  • clinical issues review (glucose levels, BP, cholesterol, ACR in urine)
  • screen for comp (eyes, feet, kidneys)
  • identify issues at subsequent visit
  • develop targets over next year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Treatment to prevent complications

A
  • smoking cessation (1 cig = 5 If diabetes)
  • aim for 140/80 bp, 130/80 if CVD or renal d, use ACEi/CCB and need >2 bp treatments
  • statin if diabetic >40 or <40 + RF for high cholesterol, aim for <4mmol/L and LDL <2 mmol/L
  • yearly digital retinal photography
  • yearly nerves and pulses in feet
  • yearly ACR and estimate GFR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How to assess glycaemic control?

A
  • HbA1c = red cells survive 3 months, less than 53 mmol/mol good control
  • SMBG = pre-prandial 4-7, post prandial 2 hour glucose 5-9
  • fructosamine = 2 weeks glycated protein, if HbA1c invalid as haemoglobinopathy and useful in pregnancy glucose monitoring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diet and exercise advice for diabetes treatment

A
  • low fat
  • low sugar
  • low salt
  • high in fibre
  • fruit and veg
  • low carbs = low GI
  • 30 mins vigorous exercise 3x a week
  • aim for 3-5% weight reduction for glycemic control
  • early oral hypoglycaemic agents if diet and lifestyle strategy fails
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hyperglycaemia therapies

A
  • sulfonylureas
  • biguanides
  • alpha glucosidase inhibitors
  • TZD (glitazones)
  • DPP4 inhibitors
  • GLP-1 analogues
  • insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the United Kingdom Prospective Diabetes Study

A
  • tight vs standard glycemic control
  • microvascular disease reduced
  • little effect on macrovascular disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do sulfonylureas and PGRs work in the pancreas?

A
  • insulin secretagogues
  • stimulate insulin release from beta cells
  • through opening K+ channels in beta cells
  • side effects = weight gain, hypoglycaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do biguanides work?

A
  • metformin
  • improved insulin sensitivity in muscle and liver so can uptake glucose
  • first line for T2D in majority
  • reduces mortality
  • reduces weight
  • sometimes reduces cancer
  • be wary with renal disease and don’t give if eGFR <30 as renally excreted and not cleared from blood
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do alpha-glucosidase inhibitors work?

A
  • drugs inhibiting intestinal absorption of glucose by blocking dissacharidases so stop converting to mono
  • lower serum glucose levels
  • but glucose moves into lower bowel attracting bacteria = wind
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do TZD work?

A
  • glitazones
  • PPRGamma receptor agonists
  • improve insulin resistance
  • work on liver and muscle
  • improve glucose uptake
  • help pancreas B cell function and content
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What do GLP-1’s do?

A
  • incretin
  • increase insulin
  • stimulate insulin from pancreas
  • decrease glucagon secretion
  • delay gastric emptying
  • suppress appetite
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is exendin-4?

A
  • GLP-1 analogue
  • injection
  • suppresses appetite and stimulates insulin release
  • only if BMI>35kg/m2 and poor glucose control
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What DPP-4 inhibitors do?

A
  • gliptins
  • inhibit enzyme breaking down GLP-1
  • oral
  • well tolerated
  • 3rd line therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When do we use different drugs according to NICE guidelines?

A
  • first line metformin
  • second add sulfonylurea
  • third glitazone/gliptin/insuin
  • then insulin + metformin + sulfonylurea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Side effects of biguanides

A
  • metformin
  • nausea
  • diarrhoea
  • lactic acidosis
  • renal failure
17
Q

Side effects of sulfonylureas and PGRs

A
  • gliclazide
  • repaglinide
  • hypoglycaemia
  • weight gain
18
Q

Side effects of glitazones

A
  • piaglitazone
  • weight gain
  • oedema
  • HF
  • post menopausal fractures
  • bladder cancer
19
Q

Side effects of alpha glucosidase inhibitors

A
  • acarbose
  • flatulence
  • diarrhoea
20
Q

Side effects of DPP-IV inhibitors

A
  • sitagliptin
  • nasopharyngitis
  • pancreatitis
21
Q

Side effects of GLP-1 agonists

A
  • exenatide
  • nausea
  • diarrhoea
  • pancreatitis
  • pancreatic cancer
22
Q

How is glucose normally metabolised?

A
  • ingest glucose
  • digested and broken down by gut enzymes
  • incretins released by gut = stimulation of insulin release from pancreas
  • glucose absorbed in small intestine
  • insulin acts on liver, muscle and adipose tissue stimulating glucose uptake
23
Q

Insulin effect on liver, muscle and adipose tissue?

A
  • liver = glucose uptake and glycogen synthesis
  • muscles = glucose uptake and glycogen synthesis
  • adipose tissue = glucose uptake
24
Q

When do insulin levels peak?

A
  • biphasic
  • short lived rapid meal related insulin peaks
  • low steady basal insulin profile
25
Q

Indications for insulin therapy

A
  • T1D = essential for life
  • T2D = inadequate glycemic control on tablets, tablet contraindication, symptomatic hyperglycaemia, pregnancy, infection/foot ulcers
26
Q

Types of insulin

A
HUMAN
- short acting Humulin S
- intermediate Humulin I
- biphasic mixture Humulin M3
ANALOGUE INSULIN
- rapid acting = lispro, novorapid
- long acting basal = lantus, levmir
- biphasic mixture = novomix 30
27
Q

Insulin injection sites

A
  • subcutaneous fat
  • abdomen fastest absorption then thighs then buttocks slowest
  • not through clothing
28
Q

Insulin regime 3 types

A
  • once daily/twice daily intermediate or long acting insulin, usually before bed or first thing in morning
  • once/twice/three times daily premixed insulin
  • basal-bolus therapy, 3 injections of rapid acting and 1 injection of long acting mimicking normal physiology